InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Daly James M, Director. Director active across 2 companies, notably Halozyme Therapeutics, INC.. Aggregated, 5 filings have been recorded. The latest transaction was filed on 5 May 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
06,206 shares0
Restricted Stock Unit
SEC:0001179110-22-002908:0·
013,568 shares0
Common Stock
SEC:0001628280-22-000412·
013,568 shares0
Common Stock
SEC:0001628280-22-000412:0·
5,230 shares
Restricted Stock Unit
SEC:0001179110-21-004971·
05,230 shares0
Restricted Stock Unit
SEC:0001179110-21-004971:0·
5 of 5 declarations
About Daly James M
James M. Daly is a Director at HALOZYME THERAPEUTICS, INC. and BELLICUM PHARMACEUTICALS, INC. In this role, he is involved in the governance of the company and strategic decision-making. His expertise in the pharmaceutical sector allows him to make significant contributions.
